Review: Advances in Intraperitoneal (Intracavitary) Administration of Synthetic Polymers for Immunotherapy and Chemotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (81)
The blood supply of neoplasms in the liver.
1954 • 1,280 citations
Intraperitoneal Cisplatin with Systemic Thiosulfate Protection
1982 • 494 citations
Contemporary Topics in Immunobiology
1977 • 410 citations
Soluble synthetic polymers as potential drug carriers
1984 • 308 citations
Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.
1980 • 249 citations
Immune Modulation Agents and their Mechanisms
1985 • 246 citations
Lipid Angiogenic Factor From Omentum
1984 • 233 citations
Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules
1974 • 222 citations
Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.
1982 • 218 citations
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.
1981 • 211 citations
Cellular and Molecular Mechanisms of Action of Bacterial Endotoxins
1979 • 198 citations
Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routes
1980 • 181 citations
Site–Specific (Targeted) Drug Delivery in Cancer Therapy
1983 • 166 citations
Immune modulation and control of neoplasia by adjuvant therapy
1978 • 152 citations
Improved regional selectivity of hepatic arterial bcnu with degradable microspheres
1982 • 144 citations
Control of neoplasia by modulation of the immune system
1977 • 130 citations
Activation of macrophages
1985 • 124 citations
Biological Effects of Polynucleotides
1971 • 120 citations
Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics
1979 • 117 citations
High volume intraperitoneal chemotherapy (?Belly bath?) for ovarian cancer
1978 • 107 citations
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.
1981 • 100 citations
Specific inhibition of antibody production. I. Protein-over loading paralysis.
1962 • 99 citations
Transport of Model Compounds across the Peritoneal Membrane in the Rat
1978 • 97 citations
Immunopharmacology of glucan: a broad spectrum enhancer of host defense mechanisms
1983 • 95 citations
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.
1984 • 94 citations
Novel Approaches to Cancer Chemotherapy
1984 • 93 citations
A Totally Implanted Injection Port System for Blood Sampling and Chemotherapy Administration
1984 • 89 citations
Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites.
1980 • 88 citations
Controlled Blocking of Hepatic Artery Flow with Enzymatically Degradable Microspheres Combined with Oncolytic Drugs
1979 • 86 citations
Pharmacology of Intraperitoneal Chemotherapy
1983 • 81 citations
Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.
1981 • 76 citations
Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma.
1984 • 70 citations
Kinetics of sodium thiosulfate, a cisplatin neutralizer
1984 • 63 citations
The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.
1984 • 59 citations
INTRACAVITARY ADRIAMYCIN NITROGEN MUSTARD AND TETRACYCLINE IN THE CONTROL OF MALIGNANT EFFUSIONS: A RANDOMIZED STUDY
1980 • 58 citations
Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial.
1977 • 55 citations
Intraperitoneal spread of malignancies and its effect on the bowel
1981 • 49 citations
The Use of Peritoneal Dialysis for Delivery of Chemotherapy to Intraperitoneal Malignancies
1980 • 46 citations
Peritoneal electrolyte absorption: analysis of portal, systemic venous, and lymphatic transport.
1968 • 45 citations
Interaction of mesothelium to intraperitoneal stimulation. I. Aggregation of peritoneal cells.
1983 • 44 citations
Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system
1984 • 42 citations
Activation of the alternative pathway of complement: efficient fluid‐phase amplification by blockade of the regulatory complement protein β1H through sulfated polyanions
1981 • 40 citations
The Growth-Regulating Activity of Polyanions: A Theoretical Discussion of Their Place in the Intercellular Environment and their role in Cell Physiology
1969 • 36 citations
Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo.
1980 • 35 citations
Antiviral Activity and Side Effects of Polyriboinosinic-Cytidylic Acid Complexes as Affected by Molecular Size
1972 • 34 citations
Drug Targeting in Cancer Therapy
1984 • 29 citations
Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas
1981 • 29 citations
Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
1983 • 26 citations
Hydrogen ion dynamics and cancer: An appraisal
1982 • 25 citations
Translocation of particles from lung lobes or the peritoneal cavity to regional lymph nodes in beagle dogs
1983 • 25 citations
Enhancement, by Two Carboxylic Acid Interferon Inducers, of Resistance Stimulated in Mice by Foot-and-Mouth Disease Vaccine
1973 • 24 citations
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer.
1984 • 24 citations
Polyinosinic-Polycytidylic Acid Toxicity
1971 • 24 citations
Some Biologically Active Copolymers of Maleic Anhydridea
1985 • 23 citations
A comparative study of histamine secretion from rat peritoneal and pleural mast cells
1982 • 22 citations
Fibronectin levels during intraperitoneal inflammation
1983 • 21 citations
Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
1975 • 21 citations
Systemic toxicity of polyinosinic acid: Polycytidylic acid in rodents and dogs
1971 • 20 citations
Clinical Science Review: The Routinization of Intraperitoneal (Intracavitary) Chemotherapy and Immunotherapy
1986 • 20 citations
Platelet Blockade of Particle Absorption from the Peritoneal Surface of the Diaphragm
1981 • 17 citations
Drug targeting: Magnetically responsive albumin microspheres—A review of the system to date
1981 • 16 citations
Reduced incidence of rat colon cancer metastases by perioperative immunostimulation with maleic anhydride-divinyl ether-2 (MVE-2)
1985 • 11 citations
Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. IV. The adjuvant effect of hemoglobin in granulocytopenic rats.
1981 • 11 citations
Studies on topical chemotherapy of tumor-contaminated surgical wounds
1963 • 11 citations
Intra-Arterial and Intracavitary Cancer Chemotherapy
2011 • 11 citations
Intraperitoneal Infusion of Non-Absorbable Steroids in the Treatment of Ascites and Sterile Peritonitis
1980 • 11 citations
The Modulation of immunity
1985 • 10 citations
Effect of Erythrocyte Debris on Reticuloendothelial Function and Susceptibility to Experimental Peritonitis
1981 • 10 citations
Mechanism of increased antitumor immunity by a synthetic polymer
1980 • 10 citations
Polyanion, Immunoprotein and Proteinase Inhibitor in Ischemic Glomerular Change
1981 • 9 citations
Polyanions and Glucose as Osmotic Agents in Simulated Peritoneal Dialysis
1983 • 9 citations
In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
1985 • 8 citations
Immunological and Tumor Responses to Various Immunotherapeutic Agents
1981 • 8 citations
Current Status of Human Cancer Immunotherapy
1981 • 6 citations
Accumulation of T cells and local antippd antibody production in lymphokine‐mediated chronic peritoneal inflammation in the guinea pig
1980 • 5 citations
Tissue distribution of adriamycin administered intraperitoneally vs. intravenously, with special emphasis on the pancreas.
1982 • 5 citations
Macrophage Activation and Antitumor Activity of Cyclohexyl‐1,3‐dioxepin and 4‐Methyl‐2‐pentonyl Maleic Anhydride Copolymersa
1985 • 4 citations
A Phase I Trial of Intracavitary Doxorubicin (Adriamycin) Alternating with Cisplatin
1984 • 4 citations
Determination of the biological response modifier MVE-2 (AD-022) in biological fluids by high-performance liquid chromatography
1983 • 3 citations
Phase I Trials and Pharmacokinetic Studies of Intraperitoneal Cisplatin, Melphalan, Methotrexate, and Cytarabine
1984 • 3 citations
Intracavity 5-fluorouracil for control of malignant effusions.
1968 • 2 citations